LEXX logo

Lexaria Bioscience (LEXX) Cash From Investing

Annual CFI

-$188.60 K
-$19.00 K-11.20%

August 31, 2024


Summary


Performance

LEXX Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLEXXcash flowmetrics:

Quarterly CFI

-$37.80 K
+$31.80 K+45.69%

November 30, 2024


Summary


Performance

LEXX Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLEXXcash flowmetrics:

TTM CFI

-$186.40 K
+$2200.00+1.17%

November 30, 2024


Summary


Performance

LEXX TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherLEXXcash flowmetrics:

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

LEXX Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-11.2%0.0%0.0%
3 y3 years-197.3%-8.6%-18.6%
5 y5 years+75.5%-8.6%-18.6%

LEXX Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-197.3%at low-71.8%+45.7%-231.7%+6.3%
5 y5-year-197.3%+75.5%-114.0%+46.5%-176.6%+85.4%
alltimeall time-127.5%+91.0%-105.2%+97.0%-127.2%+91.1%

Lexaria Bioscience Cash From Investing History

DateAnnualQuarterlyTTM
Nov 2024
-
-$37.80 K(-45.7%)
-$186.40 K(-1.2%)
Aug 2024
-$188.60 K(+11.2%)
-$69.60 K(+216.4%)
-$188.60 K(+0.6%)
May 2024
-
-$22.00 K(-61.4%)
-$187.40 K(-5.8%)
Feb 2024
-
-$57.00 K(+42.5%)
-$199.00 K(+13.9%)
Nov 2023
-
-$40.00 K(-41.5%)
-$174.70 K(+3.1%)
Aug 2023
-$169.60 K(-6.1%)
-$68.40 K(+103.6%)
-$169.50 K(+12.2%)
May 2023
-
-$33.60 K(+2.8%)
-$151.10 K(-2.8%)
Feb 2023
-
-$32.70 K(-6.0%)
-$155.50 K(-1.1%)
Nov 2022
-
-$34.80 K(-30.4%)
-$157.20 K(-13.0%)
Aug 2022
-$180.60 K(-193.1%)
-$50.00 K(+31.6%)
-$180.60 K(+38.3%)
May 2022
-
-$38.00 K(+10.5%)
-$130.60 K(-20.0%)
Feb 2022
-
-$34.40 K(-40.9%)
-$163.30 K(-215.4%)
Nov 2021
-
-$58.20 K(<-9900.0%)
$141.50 K(-27.0%)
Aug 2021
$193.90 K(-823.5%)
$0.00(-100.0%)
$193.90 K(+7.5%)
May 2021
-
-$70.70 K(-126.1%)
$180.30 K(-26.0%)
Feb 2021
-
$270.40 K(-4762.1%)
$243.50 K(-1005.2%)
Nov 2020
-
-$5800.00(-57.4%)
-$26.90 K(+0.4%)
Aug 2020
-$26.80 K(-96.5%)
-$13.60 K(+81.3%)
-$26.80 K(-42.1%)
May 2020
-
-$7500.00(<-9900.0%)
-$46.30 K(-96.4%)
Feb 2020
-
$0.00(-100.0%)
-$1.28 M(+110.3%)
Nov 2019
-
-$5700.00(-82.8%)
-$607.70 K(-21.0%)
Aug 2019
-$769.20 K(+395.0%)
-$33.10 K(-97.3%)
-$769.20 K(+0.8%)
May 2019
-
-$1.24 M(-284.9%)
-$762.90 K(-269.6%)
Feb 2019
-
$670.30 K(-500.9%)
$449.70 K(-289.8%)
Nov 2018
-
-$167.20 K(+523.9%)
-$236.90 K(+52.4%)
Aug 2018
-$155.40 K(+1502.1%)
-$26.80 K(+0.8%)
-$155.40 K(+20.8%)
May 2018
-
-$26.60 K(+63.2%)
-$128.60 K(+26.1%)
Feb 2018
-
-$16.30 K(-81.0%)
-$102.00 K(+24.8%)
Nov 2017
-
-$85.70 K(<-9900.0%)
-$81.70 K(+742.3%)
Aug 2017
-$9700.00(-51.7%)
$0.00(0.0%)
-$9700.00(-32.6%)
May 2017
-
$0.00(-100.0%)
-$14.40 K(-2.0%)
Feb 2017
-
$4000.00(-129.2%)
-$14.70 K(-52.1%)
Nov 2016
-
-$13.70 K(+191.5%)
-$30.70 K(+52.7%)
Aug 2016
-$20.10 K(-102.9%)
-$4700.00(+1466.7%)
-$20.10 K(+76.3%)
May 2016
-
-$300.00(-97.5%)
-$11.40 K(-78.1%)
Feb 2016
-
-$12.00 K(+287.1%)
-$52.10 K(-107.6%)
Nov 2015
-
-$3100.00(-177.5%)
$681.70 K(-0.5%)
Aug 2015
$684.80 K
$4000.00(-109.8%)
$684.80 K(+8.8%)
May 2015
-
-$41.00 K(-105.7%)
$629.20 K(-1.5%)
DateAnnualQuarterlyTTM
Feb 2015
-
$721.80 K(>+9900.0%)
$638.80 K(-869.6%)
Nov 2014
-
$0.00(-100.0%)
-$83.00 K(-27.3%)
Aug 2014
-$76.30 K(+8.1%)
-
-
Jul 2014
-
-$51.60 K(+64.3%)
-$114.20 K(+82.1%)
Apr 2014
-
-$31.40 K(+25.6%)
-$62.70 K(+7.4%)
Jan 2014
-
-$25.00 K(+303.2%)
-$58.40 K(-17.2%)
Oct 2013
-$70.60 K(-74.2%)
-$6200.00(+6100.0%)
-$70.50 K(-22.8%)
Jul 2013
-
-$100.00(-99.6%)
-$91.30 K(-68.9%)
Apr 2013
-
-$27.10 K(-27.0%)
-$293.10 K(+10.2%)
Jan 2013
-
-$37.10 K(+37.4%)
-$266.00 K(-3.0%)
Oct 2012
-$274.10 K(-72.7%)
-$27.00 K(-86.6%)
-$274.10 K(-71.7%)
Jul 2012
-
-$201.90 K(<-9900.0%)
-$968.60 K(+26.3%)
Apr 2012
-
$0.00(-100.0%)
-$766.70 K(-4.9%)
Jan 2012
-
-$45.20 K(-93.7%)
-$806.00 K(-19.6%)
Oct 2011
-$1.00 M(+251.5%)
-$721.50 K(<-9900.0%)
-$1.00 M(+77.0%)
Jul 2011
-
$0.00(-100.0%)
-$566.40 K(0.0%)
Apr 2011
-
-$39.30 K(-83.8%)
-$566.40 K(+7.5%)
Jan 2011
-
-$241.90 K(-15.2%)
-$527.10 K(+84.8%)
Oct 2010
-$285.20 K(+27.4%)
-$285.20 K(<-9900.0%)
-$285.20 K(+158.6%)
Jul 2010
-
$0.00(0.0%)
-$110.30 K(-8.5%)
Apr 2010
-
$0.00(0.0%)
-$120.60 K(-35.7%)
Jan 2010
-
$0.00(-100.0%)
-$187.70 K(-16.1%)
Oct 2009
-$223.80 K(-40.5%)
-$110.30 K(+970.9%)
-$223.80 K(-520.7%)
Jul 2009
-
-$10.30 K(-84.6%)
$53.20 K(-154.4%)
Apr 2009
-
-$67.10 K(+85.9%)
-$97.80 K(-204.4%)
Jan 2009
-
-$36.10 K(-121.7%)
$93.70 K(-124.9%)
Oct 2008
-$376.40 K(-82.0%)
$166.70 K(-203.3%)
-$376.40 K(-72.3%)
Jul 2008
-
-$161.30 K(-229.7%)
-$1.36 M(+12.7%)
Apr 2008
-
$124.40 K(-124.6%)
-$1.21 M(-31.5%)
Jan 2008
-
-$506.20 K(-38.0%)
-$1.76 M(-15.7%)
Oct 2007
-$2.09 M(+36.5%)
-$816.10 K(>+9900.0%)
-$2.09 M(+9.1%)
Jul 2007
-
-$7700.00(-98.2%)
-$1.91 M(-2.5%)
Apr 2007
-
-$430.40 K(-48.4%)
-$1.96 M(+22.2%)
Jan 2007
-
-$834.50 K(+30.1%)
-$1.61 M(+5.1%)
Oct 2006
-$1.53 M(+490.2%)
-$641.20 K(+1017.1%)
-$1.53 M(+72.2%)
Jul 2006
-
-$57.40 K(-22.6%)
-$888.70 K(+6.9%)
Apr 2006
-
-$74.20 K(-90.2%)
-$831.30 K(+9.8%)
Jan 2006
-
-$757.10 K
-$757.10 K
Oct 2005
-$259.20 K
-
-

FAQ

  • What is Lexaria Bioscience annual cash flow from investing activities?
  • What is the all time high annual CFI for Lexaria Bioscience?
  • What is Lexaria Bioscience annual CFI year-on-year change?
  • What is Lexaria Bioscience quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Lexaria Bioscience?
  • What is Lexaria Bioscience quarterly CFI year-on-year change?
  • What is Lexaria Bioscience TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Lexaria Bioscience?
  • What is Lexaria Bioscience TTM CFI year-on-year change?

What is Lexaria Bioscience annual cash flow from investing activities?

The current annual CFI of LEXX is -$188.60 K

What is the all time high annual CFI for Lexaria Bioscience?

Lexaria Bioscience all-time high annual cash flow from investing activities is $684.80 K

What is Lexaria Bioscience annual CFI year-on-year change?

Over the past year, LEXX annual cash flow from investing activities has changed by -$19.00 K (-11.20%)

What is Lexaria Bioscience quarterly cash flow from investing activities?

The current quarterly CFI of LEXX is -$37.80 K

What is the all time high quarterly CFI for Lexaria Bioscience?

Lexaria Bioscience all-time high quarterly cash flow from investing activities is $721.80 K

What is Lexaria Bioscience quarterly CFI year-on-year change?

Over the past year, LEXX quarterly cash flow from investing activities has changed by $0.00 (0.00%)

What is Lexaria Bioscience TTM cash flow from investing activities?

The current TTM CFI of LEXX is -$186.40 K

What is the all time high TTM CFI for Lexaria Bioscience?

Lexaria Bioscience all-time high TTM cash flow from investing activities is $684.80 K

What is Lexaria Bioscience TTM CFI year-on-year change?

Over the past year, LEXX TTM cash flow from investing activities has changed by $0.00 (0.00%)